AzTrials
AzTrials

Primary Apical PeriodontitePhase 2NCT00946634

Ozone Therapy in Endodontic Practice, in Vivo Study

A Phase 2 study testing Ozone and Aqueous Ozone in people with Primary Apical Periodontite, run by University of Sao Paulo at 1 site in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The ozone therapy has been coming up as a new therapeutic modality. Medicine has been practicing since XIX century and counted great results. It is indicated for the treatment of 260 different pathologies. Read more about this study

Who is it for?
Ages 13 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Primary Apical Periodontite
What is being tested?
Ozone and Aqueous Ozone
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteBrazil
Study dates
Jan 2009to Mar 2011
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Healthy patients
  • Radiographic evidence of apical periodontite
  • No previous root canal treatment

Who cannot join

  • Unhealthy patients
  • Regular response to sensibility test
  • Previous root canal treatment

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Fundação para o Desenvolvimento Científico e Tecnológico da Odontologia of University of Sao Paulo

    São Paulo, São Paulo, 05508-000

Other trials in Brazil

About this study

Official title: Phase 4 - Ozone Therapy in Endodontic Practice, in Vivo Study

The ozone therapy has been coming up as a new therapeutic modality. Medicine has been practicing since XIX century and counted great results. It is indicated for the treatment of 260 different pathologies. The researches in Dentistry has showed promising results, indicating a wide spread action in whole dental specialties. The great oxidative power of ozone provides a great antimicrobial effect and it increases the adenosine triphosphate (ATP) synthesis that can be considered as a general improvement of the cell metabolism, which can potentize the repair process. Thus, these facts justify the present study which will assess the increase of speed of apical periodontite repair.

Being tested
Ozone, Control (no last irrigation), Aqueous Ozone

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • OzoneDrug

    Also called Group 2

    Regular endodontic protocol preconized by University of Sao Paulo. Root canal irrigation with 1% Sodium Hypochlorite associated to Endo PTC (10mL), final irrigation with EDTA-T 17% remaining for 3 minutes. After a last foaming with ozone gas (Philozon, Santa Catarina, Brazil) at 40mg/L concentration.

  • Control (no last irrigation)Drug

    Also called Group 1

    Regular endodontic protocol preconized by University of Sao Paulo. Root canal irrigation with 1% Sodium Hypochlorite associated to Endo PTC (10mL), final irrigation with EDTA-T 17% remaining for 3 minutes.

  • Aqueous OzoneDrug

    Also called Group 3

    Regular endodontic protocol preconized by University of Sao Paulo. Root canal irrigation with 1% Sodium Hypochlorite associated to Endo PTC (10mL), final irrigation with EDTA-T 17% remaining for 3 minutes. A last irrigation with 10mL of ozonated water at 40mg/mL concentration

Study groups in NCT00946634
Study groupRoleWhat they receive
Ozone GasExperimentalEndodontic protocol preconized by University of Sao Paulo associated to ozone gas 40 mg/L
Receives: Drug: Ozone
ControlActive comparatorRegular endodontic protocol preconized by University of Sao Paulo
Receives: Drug: Control (no last irrigation)
Aqueous OzoneExperimentalEndodontic protocol preconized by University of Sao Paulo associated to Aqueous ozone 40mg/L
Receives: Drug: Aqueous Ozone

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Acceleration in repair by healing of apical periodontite

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jul 2009 (estimated)
  2. Study startJan 2009
  3. Primary completionMar 2009
  4. Study completionMar 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00946634
Sponsor's protocol ID
CEP 154/06
Status last verified
Oct 2011
First submitted
23 Jul 2009
Last updated
4 Oct 2011
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Ozone and Aqueous Ozone in people with Primary Apical Periodontite, run by University of Sao Paulo at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Oct 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Acceleration in repair by healing of apical periodontite (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Oct 2011.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in